ProfileGDS5068 / 232246_at
TitleRheumatoid arthritic synovium response to tocilizumab
OrganismHomo sapiens


baseline tocilizumab patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 GSM1116933 GSM1116935 GSM1116937 GSM1116939 GSM1116941 GSM1116943 GSM1116945 GSM1116947 GSM1116949 GSM1116951 GSM1116953 GSM1116955 GSM1116934 GSM1116936 GSM1116938 GSM1116940 GSM1116942 GSM1116944 GSM1116946 GSM1116948 GSM1116950 GSM1116952 GSM1116954 GSM1116956 50% 14% 89% 32% 13% 14% 73% 41% 67% 51% 21% 59% 32% 28% 64% 80% 30% 73% 54% 90% 2% 3% 53% 42% sort by agent sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1116933Synovial tissue prior to Tocilizumab therapy, repl 1-0.015468150
GSM1116935Synovial tissue prior to Tocilizumab therapy, repl 2-0.22125614
GSM1116937Synovial tissue prior to Tocilizumab therapy, repl 30.26255889
GSM1116939Synovial tissue prior to Tocilizumab therapy, repl 4-0.072286132
GSM1116941Synovial tissue prior to Tocilizumab therapy, repl 5-0.18305613
GSM1116943Synovial tissue prior to Tocilizumab therapy, repl 6-0.23348914
GSM1116945Synovial tissue prior to Tocilizumab therapy, repl 70.15067473
GSM1116947Synovial tissue prior to Tocilizumab therapy, repl 8-0.049887241
GSM1116949Synovial tissue prior to Tocilizumab therapy, repl 90.052715867
GSM1116951Synovial tissue prior to Tocilizumab therapy, repl 10-0.0012497951
GSM1116953Synovial tissue prior to Tocilizumab therapy, repl 11-0.15983221
GSM1116955Synovial tissue prior to Tocilizumab therapy, repl 120.036047559
GSM1116934Synovial tissue after to Tocilizumab therapy, repl 1-0.14674632
GSM1116936Synovial tissue after to Tocilizumab therapy, repl 2-0.11135328
GSM1116938Synovial tissue after to Tocilizumab therapy, repl 30.03697264
GSM1116940Synovial tissue after to Tocilizumab therapy, repl 40.28510880
GSM1116942Synovial tissue after to Tocilizumab therapy, repl 5-0.10504330
GSM1116944Synovial tissue after to Tocilizumab therapy, repl 60.091076473
GSM1116946Synovial tissue after to Tocilizumab therapy, repl 70.0012497954
GSM1116948Synovial tissue after to Tocilizumab therapy, repl 80.29455790
GSM1116950Synovial tissue after to Tocilizumab therapy, repl 9-0.6156832
GSM1116952Synovial tissue after to Tocilizumab therapy, repl 10-0.4103573
GSM1116954Synovial tissue after to Tocilizumab therapy, repl 110.0074582153
GSM1116956Synovial tissue after to Tocilizumab therapy, repl 12-0.028915942